P2.103 Antidyskinetic effects of levetiracetam on levodopa-induced dyskinesias in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
✍ Scribed by M. Löhle; M. Wolz; K. Strecker; C. Schneider; U. Schwanebeck; H. Reichmann; X. Grählert; J. Schwarz; A. Storch
- Book ID
- 117753657
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 82 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s
Mood fluctuations related to levodopa (LD) dosing are well-known psychiatric complications of Parkinson's disease (PD). No formal studies explored how affective response to LD relates to the type of motor response to oral LD (stable or wearing-off) and to different pharmacokinetic profiles of oral L